Strides Pharma Science Ltd Q4 FY2023-2024 Results: Summary
Revenue | ₹1,070.56Cr |
Net Profits | ₹18.18Cr |
Net Profit Margins | 1.70% |
Highlights
Revenue:
Strides Pharma Science Ltd’s revenue jumped 5.63% since last year same period to ₹1,070.56Cr in the Q4 2023-2024. On a quarterly growth basis, Strides Pharma Science Ltd has generated -2.73% fall in its revenue since last 3-months.
Net Profits:
Strides Pharma Science Ltd’s net profit jumped 290.57% since last year same period to ₹18.18Cr in the Q4 2023-2024. On a quarterly growth basis, Strides Pharma Science Ltd has generated -63.4% fall in its net profits since last 3-months.
Net Profit Margins:
Strides Pharma Science Ltd’s net profit margin jumped 280.41% since last year same period to 1.70% in the Q4 2023-2024. On a quarterly growth basis, Strides Pharma Science Ltd has generated -62.37% fall in its net profit margins since last 3-months.
